SP
Saundra L Pelletier
Chief Executive OfficerDirector

Saundra L Pelletier insider trades: Evofem Biosciences (EVFM) stock buys and sales

Chief Executive Officer, Evofem Biosciences Last trade May 27, 2022 35 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2018
2
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Saundra reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 27, 2022EVFM↑ Buy$50K
Dec 20, 2021EVFM↑ Buy$51K
Jul 26, 2021TCON↑ Buy$25K
Jun 10, 2021EVFM↑ Buy$52K
Mar 9, 2021EVFM↑ Buy$103K
Sep 8, 2020EVFM↓ Sell$399K
Jun 15, 2020TCON↑ Buy$11K
Jan 13, 2020EVFM↓ Sell$20K
Jan 2, 2020EVFM↓ Sell$41K
Dec 2, 2019EVFM↓ Sell$146K
Nov 21, 2019EVFM↓ Sell$60K
Aug 10, 2018EVFM↑ Buy$21K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Saundra L Pelletier's insider trades

Saundra L Pelletier is Chief Executive Officer at Evofem Biosciences (EVFM). Since Aug 10, 2018, Saundra has reported 7 open-market purchases worth $312K and 5 sales worth $666K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (14 filings), shares withheld for taxes (10 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EVFM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.